相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The role of the Technical Review Panel of the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria: an analysis of grant recommendations
Guido Schmidt-Traub
HEALTH POLICY AND PLANNING (2018)
Time for high-burden countries to lead the tuberculosis research agenda
Madhukar Pai
PLOS MEDICINE (2018)
MR1-restricted mucosal-associated invariant T (MAIT) cells respond to mycobacterial vaccination and infection in nonhuman primates
J. M. Greene et al.
MUCOSAL IMMUNOLOGY (2017)
Heterologous boosting with recombinant VSV-846 in BCG-primed mice confers improved protection against Mycobacterium infection
Ming Zhang et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guerin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK
Punam Mangtani et al.
HEALTH TECHNOLOGY ASSESSMENT (2017)
Novel approaches to tuberculosis vaccine development
Stefan H. E. Kaufmann et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
HLA-E Presents Glycopeptides from the Mycobacterium tuberculosis Protein MPT32 to Human CD8+ T cells
Melanie J. Harriff et al.
SCIENTIFIC REPORTS (2017)
Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine
Rafael Prados-Rosales et al.
PLOS PATHOGENS (2017)
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
Keertan Dheda et al.
LANCET RESPIRATORY MEDICINE (2017)
Comprehensive definition of human immunodominant CD8 antigens in tuberculosis
Deborah A. Lewinsohn et al.
NPJ VACCINES (2017)
CD8+T cell programming by cytomegalovirus vectors: applications in prophylactic and therapeutic vaccination
Klaus Fruh et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis A Randomized Trial
Richard N. van Zyl-Smit et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Pulmonary but Not Subcutaneous Delivery of BCG Vaccine Confers Protection to Tuberculosis-Susceptible Mice by an Interleukin 17-Dependent Mechanism
Nacho Aguilo et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
The potential impact of BCG vaccine supply shortages on global paediatric tuberculosis mortality
Rebecca C. Harris et al.
BMC MEDICINE (2016)
IFN-γ and IgA against non-methylated heparin-binding hemagglutinin as markers of protective immunity and latent tuberculosis: Results of a longitudinal study from an endemic setting
Mulugeta Belay et al.
JOURNAL OF INFECTION (2016)
Vaccination Against Tuberculosis With Whole-Cell Mycobacterial Vaccines
Thomas J. Scriba et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study
Patrick Nguipdop-Djomo et al.
LANCET INFECTIOUS DISEASES (2016)
BCG vaccination: a long-lasting protection against tuberculosis? Reply
Patrick Nguipdop-Djomo et al.
LANCET INFECTIOUS DISEASES (2016)
Global Efforts in the Development of Vaccines for Tuberculosis: Requirements for Improved Vaccines Against Mycobacterium tuberculosis
P. Mendez-Samperio
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2016)
Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations
S. Sharpe et al.
TUBERCULOSIS (2016)
Novel approaches to preclinical research and TB vaccine development
Kenneth Barry Walker et al.
TUBERCULOSIS (2016)
Immunopathogenesis of tuberculosis and novel mechanisms of vaccine activity
Lewis K. Schrager et al.
TUBERCULOSIS (2016)
Adenovirus type 35-vectored tuberculosis vaccine has an acceptable safety and tolerability profile in healthy, BCG-vaccinated, QuantiFERON®-TB Gold (+) Kenyan adults without evidence of tuberculosis
Douglas S. Walsh et al.
VACCINE (2016)
Mucosal BCG Vaccination Induces Protective Lung-Resident Memory T Cell Populations against Tuberculosis
Carolina Perdomo et al.
MBIO (2016)
T-cell activation is an immune correlate of risk in BCG vaccinated infants
Helen A. Fletcher et al.
NATURE COMMUNICATIONS (2016)
Patients with Tuberculosis Have a Dysfunctional Circulating B-Cell Compartment, Which Normalizes following Successful Treatment
Simone A. Joosten et al.
PLOS PATHOGENS (2016)
Tuberculosis
Madhukar Pai et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Different human vaccine adjuvants promote distinct antigenin-dependent immunological signatures tailored to different pathogens
Niels Peter H. Knudsen et al.
SCIENTIFIC REPORTS (2016)
B cells and antibodies in the defense against Mycobacterium tuberculosis infection
Jacqueline M. Achkar et al.
IMMUNOLOGICAL REVIEWS (2015)
Enhanced and durable protective immune responses induced by a cocktail of recombinant BCG strains expressing antigens of multistage of Mycobacterium tuberculosis
Jinping Liang et al.
MOLECULAR IMMUNOLOGY (2015)
The balance between protective and pathogenic immune responses in the TB-infected lung
Ian M. Orme et al.
NATURE IMMUNOLOGY (2015)
Tuberculosis vaccines: Time for a global strategy
Stefan H. E. Kaufmann et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults
Angelique Kany Kany Luabeya et al.
VACCINE (2015)
Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial
Francois Spertini et al.
LANCET RESPIRATORY MEDICINE (2015)
Tuberculosis among migrant populations in the European Union and the European Economic Area
Anna Odone et al.
EUROPEAN JOURNAL OF PUBLIC HEALTH (2015)
Multidrug-resistant tuberculosis around the world: what progress has been made?
Dennis Falzon et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Vaccine against tuberculosis: what's new?
Carlotta Montagnani et al.
BMC INFECTIOUS DISEASES (2014)
Tuberculosis in BRICS: challenges and opportunities for leadership within the post-2015 agenda
Jacob Creswell et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2014)
Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials
Punam Mangtani et al.
CLINICAL INFECTIOUS DISEASES (2014)
The BCG replacement vaccine VPM1002: from drawing board to clinical trial
Stefan H. E. Kaufmann et al.
EXPERT REVIEW OF VACCINES (2014)
Protection against Mycobacterium leprae Infection by the ID83/GLA-SE and ID93/GLA-SE Vaccines Developed for Tuberculosis
Malcolm S. Duthie et al.
INFECTION AND IMMUNITY (2014)
Safety and Immunogenicity of H1/IC31®, an Adjuvanted TB Subunit Vaccine, in HIV-Infected Adults with CD4+Lymphocyte Counts Greater than 350 cells/mm3 : A Phase II, Multi-Centre, Double-Blind, Randomized, Placebo-Controlled Trial
Klaus Reither et al.
PLOS ONE (2014)
Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries
Gwenan M. Knight et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine when given as a booster to BCG in Gambian infants: An open-label randomized controlled trial
Olubukola T. Idoko et al.
TUBERCULOSIS (2014)
Induction and Regulation of T-Cell Immunity by the Novel Tuberculosis Vaccine M72/AS01 in South African Adults
Cheryl L. Day et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
A Randomized, Controlled Dose-Finding Phase II Study of the M72/AS01 Candidate Tuberculosis Vaccine in Healthy PPD-Positive Adults
Jaime Montoya et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines
Satria A. Prabowo et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2013)
ESAT-6 (EsxA) and TB10.4 (EsxH) Based Vaccines for Pre-and Post-Exposure Tuberculosis Vaccination
Truc Hoang et al.
PLOS ONE (2013)
Improved CD4(+) T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: A randomized trial
Isabel Leroux-Roels et al.
VACCINE (2013)
Risk of Progression to Active Tuberculosis Following Reinfection With Mycobacterium tuberculosis
Jason R. Andrews et al.
CLINICAL INFECTIOUS DISEASES (2012)
Bioinformatic and Empirical Analysis of Novel Hypoxia-Inducible Targets of the Human Antituberculosis T Cell Response
Hannah P. Gideon et al.
JOURNAL OF IMMUNOLOGY (2012)
Prime-Boost Vaccination with rBCG/rAd35 Enhances CD8+ Cytolytic T-Cell Responses in Lesions from Mycobacterium Tuberculosis-Infected Primates
Sayma Rahman et al.
MOLECULAR MEDICINE (2012)
Efficacy of Mycobacterium indicus pranii Immunotherapy as an Adjunct to Chemotherapy for Tuberculosis and Underlying Immune Responses in the Lung
Ankan Gupta et al.
PLOS ONE (2012)
Protective efficacy of Mycobacterium indicus pranii against tuberculosis and underlying local lung immune responses in guinea pig model
Ankan Gupta et al.
VACCINE (2012)
Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go?
Tom H. M. Ottenhoff et al.
PLOS PATHOGENS (2012)
Current and novel approaches to vaccine development against tuberculosis
Mark J. Cayabyab et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2012)
A multistage tuberculosis vaccine that confers efficient protection before and after exposure
Claus Aagaard et al.
NATURE MEDICINE (2011)
Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection
Jaap T. van Dissel et al.
VACCINE (2011)
First in humans: A new molecularly defined vaccine shows excellent safety and strong induction of long-lived Mycobacterium tuberculosis-specific Th1-cell like responses
Tom H. Ottenhoff et al.
HUMAN VACCINES (2010)
Mycobacterium vaccae vaccine to prevent tuberculosis in high risk people: A meta-analysis
Xiao-yan Yang et al.
JOURNAL OF INFECTION (2010)
A Defined Tuberculosis Vaccine Candidate Boosts BCG and Protects Against Multidrug-Resistant Mycobacterium tuberculosis
Sylvie Bertholet et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naive human volunteers
Jaap T. van Dissel et al.
VACCINE (2010)
IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses
Carola Schellack et al.
VACCINE (2006)
Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis
J Wang et al.
JOURNAL OF IMMUNOLOGY (2004)
Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara
NP Goonetilleke et al.
JOURNAL OF IMMUNOLOGY (2003)
分享论文
